Phase 2 study of tabalumab, a human anti‐B‐cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma
Raje, Noopur S., Moreau, Philippe, Terpos, Evangelos, Benboubker, Lotfi, Grząśko, Norbert, Holstein, Sarah A., Oriol, Albert, Huang, Shang‐Yi, Beksac, Meral, Kuliczkowski, Kazimierz, Tai, Datchen F., Wooldridge, James E., Conti, Ilaria, Kaiser, Christopher J., Nguyen, Tuan S., Cronier, Damien M., Palumbo, Antonio
Published in British journal of haematology (01.03.2017)
Published in British journal of haematology (01.03.2017)
Get full text
Journal Article
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer
Gordon, Alan N, Teneriello, Michael, Janicek, Mike F, Hines, Jeffrey, Lim, Peter C, Chen, M. Dwight, Vaccarello, Luis, Homesley, Howard D, McMeekin, Scott, Burkholder, Tiana L, Wang, Yanping, Zhao, Luping, Orlando, Mauro, Obasaju, Coleman K, Gill, John F, Tai, Datchen F
Published in Gynecologic oncology (01.12.2011)
Published in Gynecologic oncology (01.12.2011)
Get full text
Journal Article
Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer
Richards, Donald A., Loesch, David, Vukelja, Svetislava J., Wu, Hillary, Hyman, William J., Nieves, Jeffery, Wang, Yunfei, Hu, Simin, Shonukan, Oluwatoyin O., Tai, Datchen F.
Published in Investigational new drugs (01.10.2011)
Published in Investigational new drugs (01.10.2011)
Get full text
Journal Article
Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: Results of a three-arm Phase I study
Alvarez, Ronald D, Mannel, Robert, García, Agustin A, Gallion, Holly H, Lucci, Joseph, Kilgore, Larry C, Numnum, Thomas M, Zou, Sharon Xiaohan, Orlando, Mauro, Tai, Datchen F
Published in Gynecologic oncology (01.12.2009)
Published in Gynecologic oncology (01.12.2009)
Get full text
Journal Article
Phase III Trial of Induction Gemcitabine or Paclitaxel Plus Carboplatin Followed by Elective Paclitaxel Consolidation in Ovarian Cancer: Interim Analysis of Induction Chemotherapy
Gordon, Alan N, Teneriello, Michael, Lim, Peter, Janicek, Mike F, Burkholder, Tiana L, Wang, Yanping, Orlando, Mauro, Obasaju, Coleman K, Gill, John F, Tai, Datchen F
Published in Clinical ovarian cancer and other gynecologic malignancies (01.11.2009)
Published in Clinical ovarian cancer and other gynecologic malignancies (01.11.2009)
Get full text
Journal Article
Phase III Trial of Induction Gemcitabine or Paclitaxel Plus Carboplatin Followed by Elective Paclitaxel Consolidation in Ovarian Cancer: Interim Analysis of Induction Chemotherapy
Gordon, Alan N, Teneriello, Michael, Lim, Peter, Janicek, Mike F, Burkholder, Tiana L, Wang, Yanping, Orlando, Mauro, Obasaju, Coleman K, Gill, John F, Tai, Datchen F
Published in Clinical ovarian cancer and other gynecologic malignancies (01.09.2009)
Published in Clinical ovarian cancer and other gynecologic malignancies (01.09.2009)
Get full text
Journal Article